These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15196346)

  • 21. Diagnosis of chronic obstructive pulmonary disease and differentiation from asthma.
    Scott JA; Mahler DA
    Curr Opin Pulm Med; 1995 Mar; 1(2):144-9. PubMed ID: 15786604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Markers of airway inflammation in pulmonary diseases assessed by induced sputum.
    Dragonieri S; Tongoussouva O; Zanini A; Imperatori A; Spanevello A
    Monaldi Arch Chest Dis; 2009 Sep; 71(3):119-26. PubMed ID: 19999958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sputum induction in children with difficult asthma: safety, feasibility, and inflammatory cell pattern.
    Lex C; Payne DN; Zacharasiewicz A; Li AM; Wilson NM; Hansel TT; Bush A
    Pediatr Pulmonol; 2005 Apr; 39(4):318-24. PubMed ID: 15678506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in sputum composition during 15 min of sputum induction in healthy subjects and patients with asthma and chronic obstructive pulmonary disease.
    Toungoussova O; Migliori GB; Foschino Barbaro MP; Esposito LM; Dragonieri S; Carpagnano GE; Salerno FG; Neri M; Spanevello A
    Respir Med; 2007 Jul; 101(7):1543-8. PubMed ID: 17258444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional assessment of chronic obstructive pulmonary disease.
    Downs CA
    J Am Acad Nurse Pract; 2011 Apr; 23(4):161-7. PubMed ID: 21489009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and application of induced sputum analysis in childhood asthma.
    Covar RA; Spahn JD; Martin RJ; Silkoff PE; Sundstrom DA; Murphy J; Szefler SJ
    J Allergy Clin Immunol; 2004 Sep; 114(3):575-82. PubMed ID: 15356559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sputum eosinophilia in idiopathic pulmonary fibrosis.
    Birring SS; Parker D; McKenna S; Hargadon B; Brightling CE; Pavord ID; Bradding P
    Inflamm Res; 2005 Feb; 54(2):51-6. PubMed ID: 15750711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease.
    Brightling CE; McKenna S; Hargadon B; Birring S; Green R; Siva R; Berry M; Parker D; Monteiro W; Pavord ID; Bradding P
    Thorax; 2005 Mar; 60(3):193-8. PubMed ID: 15741434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical applications of induced sputum.
    Brightling CE
    Chest; 2006 May; 129(5):1344-8. PubMed ID: 16685028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induced sputum and exhaled nitric oxide as noninvasive markers of airway inflammation from work exposures.
    Lemiere C
    Curr Opin Allergy Clin Immunol; 2007 Apr; 7(2):133-7. PubMed ID: 17351465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sinonasal pathology in nonallergic asthma and COPD: 'united airway disease' beyond the scope of allergy.
    Hens G; Vanaudenaerde BM; Bullens DM; Piessens M; Decramer M; Dupont LJ; Ceuppens JL; Hellings PW
    Allergy; 2008 Mar; 63(3):261-7. PubMed ID: 18053011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Induced sputum to assess airway inflammation].
    Wang Z
    Zhonghua Jie He He Hu Xi Za Zhi; 2000 Dec; 23(12):765-8. PubMed ID: 11778481
    [No Abstract]   [Full Text] [Related]  

  • 33. Respiratory symptoms, bronchial hyper-responsiveness, and eosinophilic airway inflammation in patients with moderate-to-severe atopic dermatitis.
    Kyllönen H; Malmberg P; Remitz A; Rytilä P; Metso T; Helenius I; Haahtela T; Reitamo S
    Clin Exp Allergy; 2006 Feb; 36(2):192-7. PubMed ID: 16433856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic obstructive pulmonary disease: diagnostic considerations.
    Dewar M; Curry RW
    Am Fam Physician; 2006 Feb; 73(4):669-76. PubMed ID: 16506711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of macrophage surface markers in induced sputum of patients with chronic obstructive pulmonary disease.
    Domagała-Kulawik J; Maskey-Warzechowska M; Hermanowicz-Salamon J; Chazan R
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 4():75-84. PubMed ID: 17072032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Test your knowledge. A rare cause of breathlessness.
    Burdon J
    Aust Fam Physician; 2002 Sep; 31(9):839-40. PubMed ID: 12402704
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical application of noninvasive monitoring of airway inflammation in asthma].
    Liu CT
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Mar; 31(3):169-72. PubMed ID: 18785514
    [No Abstract]   [Full Text] [Related]  

  • 38. Standardised methodology of sputum induction and processing.
    Djukanović R; Sterk PJ; Fahy JV; Hargreave FE
    Eur Respir J Suppl; 2002 Sep; 37():1s-2s. PubMed ID: 12361359
    [No Abstract]   [Full Text] [Related]  

  • 39. Bronchodilator reversibility, airway eosinophilia and anti-inflammatory effects of inhaled fluticasone in COPD are not related.
    Reid DW; Wen Y; Johns DP; Williams TJ; Ward C; Walters EH
    Respirology; 2008 Nov; 13(6):799-809. PubMed ID: 18811878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exhaled breath condensate and airway inflammation.
    Hoffmeyer F; Raulf-Heimsoth M; Brüning T
    Curr Opin Allergy Clin Immunol; 2009 Feb; 9(1):16-22. PubMed ID: 19532089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.